Two plaintiffs—one from New York and the other from Virginia—recently filed a new generic Zantac (ranitidine) class-action lawsuit in the U.S. District Court for the Southern District of New York. The plaintiffs claim that generic ranitidine manufacturer Perrigo Company put consumers at risk when selling…
Kendra Goldhirsch is an Associate at the Firm. Ms. Goldhirsch is a 2015 New York Metro Super Lawyers Rising Star. Her practice focuses on national product liability litigation and mass torts.
Before joining Chaffin Luhana, Ms. Goldhirsch was an associate at another prominent national mass tort firm where she represented hundreds of victims in pharmaceutical and medical device cases. In 2014, Ms. Goldhirsch was a member of the Actos multidistrict-litigation trial team that resulted in a multi-billion dollar verdict against the manufacturers and distributors of the drug. In 2012, Ms. Goldhirsch was a member of the trial team responsible for securing a $9-million verdict against the maker of Accutane. Ms. Goldhirsch was also involved in litigating numerous complex product claims that resulted in substantial settlements for her clients.
Ms. Goldhirsch received her Bachelors Degree from Boston University and her Juris Doctorate from Brooklyn Law School. While attending Brooklyn Law School, Ms. Goldhirsch volunteered in the Safe Harbor Clinic as a French language translator for foreign nationals seeking asylum in the United States.
Ms. Goldhirsch is admitted to practice in New York and the United States District Courts for the Southern and Eastern District of New York.